Colchicine to prevent another stroke after a mild stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether taking colchicine (a medicine used for gout and inflammation) after a recent mild or moderate stroke can help prevent another stroke. If it works, it could offer a new way to reduce stroke risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a mild or moderate stroke (not a severe one) confirmed by a brain scan.
- Your most recent stroke happened between 7 and 30 days ago.
- You do not have an allergy to colchicine, inflammatory bowel disease, or chronic diarrhea.
- You do not have severe liver or kidney problems, and your blood counts are not too low.
- You are not taking certain medications that can interact with colchicine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether colchicine, a medicine that reduces inflammation, can help people recover better and prevent future heart or brain problems after a brain bleed. It may be an option for those with certain health conditions or risk factors.
This Phase 3 study tests whether low-dose colchicine added to ticagrelor (a blood-thinning medicine) helps prevent another ischemic stroke in people whose first stroke was caused by clogged arteries. It aims to lower the risk of repeat stroke after recovery from a recent event.
This Phase 2 trial tests whether colchicine can help people with significant narrowing in brain arteries (from atherosclerosis) after a recent stroke or “mini-stroke.” It aims to reduce the risk related to this condition during the early period after symptoms begin.
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This trial tests if colchicine can reduce the risk of another stroke caused by bleeding in the brain due to a condition called cerebral amyloid angiopathy (CAA). You may qualify if you've recently had a brain bleed from CAA and have certain signs on brain scans.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.